Ret Targeted News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ret Targeted. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ret Targeted Today - Breaking & Trending Today

Lessons from LIBRETTO-431 Trial in RET+ NSCLC

Published: November 17, 2023

An overview of data presented at ESMO 2023 on the LIBRETTO-431 trial of selpercatinib in RET+ NSCLC.

Source: ajmc.com

Related Topics:

Patrick FordePost Conference PerspectivesNon Squamous DiseaseRet TargetedRet FusionOncogene SubtypesRet Fusion Positive NsclcPlatinum Doublet ChemotherapyTargeted TherapyLibretto 431Ntrk FusionsNon Squamous Lung Cancer